BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angelopoulou E, Paudel YN, Papageorgiou SG, Piperi C. APOE Genotype and Alzheimer's Disease: The Influence of Lifestyle and Environmental Factors. ACS Chem Neurosci 2021;12:2749-64. [PMID: 34275270 DOI: 10.1021/acschemneuro.1c00295] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Angelopoulou E, Pyrgelis ES, Piperi C. Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence. Molecules 2022;27. [PMID: 36500540 DOI: 10.3390/molecules27238448] [Reference Citation Analysis]
2 Muñoz Herrera OM, Zivkovic AM. Microglia and Cholesterol Handling: Implications for Alzheimer's Disease. Biomedicines 2022;10. [PMID: 36551857 DOI: 10.3390/biomedicines10123105] [Reference Citation Analysis]
3 Hester K, Kirrane E, Anderson T, Kulikowski N, Simmons JE, Lehmann DM. Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: A systematic evidence map protocol. Environment International 2022;169:107528. [DOI: 10.1016/j.envint.2022.107528] [Reference Citation Analysis]
4 Tajik M, Danielli E, Sharma B, Noseworthy MD. A review of molecular and genetic factors for determining mild traumatic brain injury severity and recovery. Brain Disorders 2022. [DOI: 10.1016/j.dscb.2022.100058] [Reference Citation Analysis]
5 Migliore L, Coppedè F. Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics. Nat Rev Neurol 2022. [PMID: 36180553 DOI: 10.1038/s41582-022-00714-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zieneldien T, Kim J, Sawmiller D, Cao C. The Immune System as a Therapeutic Target for Alzheimer’s Disease. Life 2022;12:1440. [DOI: 10.3390/life12091440] [Reference Citation Analysis]
7 Alagarsamy J, Jaeschke A, Hui DY. Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases. IJMS 2022;23:9892. [DOI: 10.3390/ijms23179892] [Reference Citation Analysis]
8 Zhang Y, Li C, Xu H, Lin B, Chen J, Zhao Y, Yang J, Zhang X, Shi Y. Pterosin sesquiterpenes and lignans from Pteris laeta Wall. and their neuroprotective bioactivity. Journal of Molecular Structure 2022;1261:132890. [DOI: 10.1016/j.molstruc.2022.132890] [Reference Citation Analysis]
9 Lopez-font I, Lennol MP, Iborra-lazaro G, Zetterberg H, Blennow K, Sáez-valero J. Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer’s Disease Patients. IJMS 2022;23:7522. [DOI: 10.3390/ijms23147522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Angelopoulou E, Bougea A, Papageorgiou SG, Villa C. Psychosis in Parkinson's Disease: A Lesson from Genetics. Genes (Basel) 2022;13:1099. [PMID: 35741861 DOI: 10.3390/genes13061099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Stoccoro A, Baldacci F, Ceravolo R, Giampietri L, Tognoni G, Siciliano G, Migliore L, Coppedè F. Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals. Int J Mol Sci 2022;23:5393. [PMID: 35628202 DOI: 10.3390/ijms23105393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Coad BM, Ghomroudi PA, Sims R, Aggleton JP, Vann SD, Metzler-baddeley C. Apolipoprotein ε4 modifies obesity-related atrophy in the hippocampal formation of cognitively healthy adults. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.02.004] [Reference Citation Analysis]
13 Coad BM, Ghomroudi PA, Sims R, Aggleton JP, Vann SD, Metzler-baddeley C. Apolipoprotein ε4 modifies obesity-related atrophy in the hippocampal formation of cognitively healthy adults.. [DOI: 10.1101/2021.11.12.468385] [Reference Citation Analysis]
14 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Sampani K. Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochem Pharmacol 2021;193:114809. [PMID: 34673016 DOI: 10.1016/j.bcp.2021.114809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]